154 related articles for article (PubMed ID: 11788624)
1. Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days.
Brown A; Cheng L; Lin S; Baird DT
J Clin Endocrinol Metab; 2002 Jan; 87(1):63-70. PubMed ID: 11788624
[TBL] [Abstract][Full Text] [Related]
2. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
Cameron ST; Thong KJ; Baird DT
Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term treatment with low-dose mifepristone on the endometrium.
Baird DT; Brown A; Critchley HO; Williams AR; Lin S; Cheng L
Hum Reprod; 2003 Jan; 18(1):61-8. PubMed ID: 12525442
[TBL] [Abstract][Full Text] [Related]
4. Toward developing a once-a-month pill: a double-blind, randomized, controlled trial of the effect of three single doses of mifepristone given at midcycle on the pattern of menstrual bleeding.
Narvekar N; Glasier A; Dada K; Van der Spuy Z; Ho PC; Cheng L; Baird DT
Fertil Steril; 2006 Oct; 86(4):819-24. PubMed ID: 17027354
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term low-dose mifepristone on reproductive function in women.
Croxatto HB; Kovács L; Massai R; Resch BA; Fuentealba B; Salvatierra AM; Croxatto HD; Zalányi S; Viski S; Krenács L
Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
[TBL] [Abstract][Full Text] [Related]
6. Contraceptive use of antiprogestin.
Bygdeman M; Danielsson KG; Marions L; Swahn ML
Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):103-7. PubMed ID: 10427485
[TBL] [Abstract][Full Text] [Related]
7. Weekly contraception with mifepristone.
Pei K; Xiao B; Jing X; Lu S; Wei L; Zhao H
Contraception; 2007 Jan; 75(1):40-4. PubMed ID: 17161123
[TBL] [Abstract][Full Text] [Related]
8. Effects of a preovulatory single low dose of mifepristone on ovarian function.
van der Stege JG; Pahl-van Beest EH; Beerthuizen RJ; van Lunsen RH; Scholten PC; Bogchelman DH
Eur J Contracept Reprod Health Care; 2006 Jun; 11(2):104-8. PubMed ID: 16854683
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose mifepristone administration in two different 14-day regimens on the menstrual cycle and endometrial development: a randomized controlled trial.
Chen Y; Wang W; Zhuang Y; Chen X; Huang L
Contraception; 2011 Jul; 84(1):64-70. PubMed ID: 21664512
[TBL] [Abstract][Full Text] [Related]
10. Low-dose mifepristone for contraception: a weekly versus planned postcoital randomized pilot study.
Godfrey EM; Mawson JT; Stanwood NL; Fielding SL; Schaff EA
Contraception; 2004 Jul; 70(1):41-6. PubMed ID: 15208051
[TBL] [Abstract][Full Text] [Related]
11. A novel estrogen-free oral contraceptive pill for women: multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel).
Lakha F; Ho PC; Van der Spuy ZM; Dada K; Elton R; Glasier AF; Critchley HO; Williams AR; Baird DT
Hum Reprod; 2007 Sep; 22(9):2428-36. PubMed ID: 17609247
[TBL] [Abstract][Full Text] [Related]
12. [Effects of mifepristone of different doses on emergency contraception, a randomized double-blind study].
Xiao BL; von Hertzen H; Zhao H; Piaggio G; Wu SC; Huang J; Weng LJ; Zhang LJ; Cheng LN; Ren FM; He CH; Gui YL; Huang ZJ; Lei ZW; Zhu MH; Song LJ; Cao XM; Wang RF; Ding WH; Mei QM; Ni FX; Zheng N
Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):813-8. PubMed ID: 12895329
[TBL] [Abstract][Full Text] [Related]
13. The possible use of antiprogestins for contraception.
Bygdeman M; Danielsson KG; Swahn ML
Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644
[TBL] [Abstract][Full Text] [Related]
14. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.
von Hertzen H; Piaggio G; Ding J; Chen J; Song S; Bártfai G; Ng E; Gemzell-Danielsson K; Oyunbileg A; Wu S; Cheng W; Lüdicke F; Pretnar-Darovec A; Kirkman R; Mittal S; Khomassuridze A; Apter D; Peregoudov A;
Lancet; 2002 Dec; 360(9348):1803-10. PubMed ID: 12480356
[TBL] [Abstract][Full Text] [Related]
15. Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor.
Narvekar N; Critchley HO; Cheng L; Baird DT
Hum Reprod; 2006 Sep; 21(9):2312-8. PubMed ID: 16807278
[TBL] [Abstract][Full Text] [Related]
16. Emergency contraception with mifepristone and levonorgestrel: mechanism of action.
Marions L; Hultenby K; Lindell I; Sun X; Ståbi B; Gemzell Danielsson K
Obstet Gynecol; 2002 Jul; 100(1):65-71. PubMed ID: 12100805
[TBL] [Abstract][Full Text] [Related]
17. Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation.
Croxatto HB; Brache V; Pavez M; Cochon L; Forcelledo ML; Alvarez F; Massai R; Faundes A; Salvatierra AM
Contraception; 2004 Dec; 70(6):442-50. PubMed ID: 15541405
[TBL] [Abstract][Full Text] [Related]
18. Changes in vaginal morphology, steroid receptor and natural antimicrobial content following treatment with low-dose mifepristone.
Narvekar N; Lakha F; Critchley HO; Glasier AF; Williams AR; Leminen R; Heikinheimo O; Kelly RW; Baird DT
Contraception; 2007 Apr; 75(4):271-80. PubMed ID: 17362705
[TBL] [Abstract][Full Text] [Related]
19. Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century.
Spitz IM
Contraception; 2010 Nov; 82(5):442-52. PubMed ID: 20933118
[TBL] [Abstract][Full Text] [Related]
20. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D
Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
